Company Search:
Advanced Search
Sponsored Links
UCB Sa Company Snapshot
UCB Sa operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares UCB Sa with three other pharmaceutical manufacturers in Europe: Lonza Group AG of Switzerland (2015 sales of 3.80 billion Swiss Francs [US$3.75 billion] of which 57% was Specialty Ingredients), Protek PAO of Russia (195.31 billion Russian Rubles [US$3.27 billion] of which 81% was Distribution), and Shire PLC which is based in the United Kingdom (£4.21 billion [US$5.14 billion] of which 100% was Pharmaceuticals & Genetic Therapies).

Sales Analysis. UCB Sa reported sales of 3.88 billion Euro (US$4.10 billion) for the year ending December of 2015. This represents an increase of 15.9% versus 2014, when the company's sales were 3.34 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for UCB Sa
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 65.40
(Figures in Euro)
1 Week -0.7%   13 Weeks 11.7%  
4 Weeks -1.5%   52 Weeks -14.7%  
UCB Sa Key Data:
  Ticker: UCB Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,876,000,000
(Year Ending Jan 2016).
Employees: 7,788
  Currency: Euro Market Cap: 12,314,283,524
  Fiscal Yr Ends: December Shares Outstanding: 188,291,797
  Share Type: Actions Ordinaires Closely Held Shares: 73,298,914
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.